HuR, a member of the ELAV family of AU-rich RNA-binding proteins, is present in a variety of tissues and is directly involved in stabilizing labile AU-rich messenger RNAs. We have found that treating the human HepG2 cell line with 10 nM dihydrotestosterone (DHT) for 48 h decreases the total level of HuR by 75%. DHT decreases both cytosolic and nuclear HuR levels in HepG2 cells, but increases HuR levels in polyribosomes by 325%. In BALB/c mice, HuR levels in the submaxillary salivary gland (SMG) and the kidney display a dramatic sexual dimorphism, but those in the spleen and thyroid do not. DHT (200 g) causes total HuR levels in female SMG and kidney to fall progressively, whereas, conversely, orchiectomy of males causes HuR levels to rise in these two tissues by 800% and 200%, respectively. As an internal control we probed the same blots for AUF1, a destabilizing AU-binding protein, and confirmed our previous findings showing that the cytosolic p37 isoform of AUF1 shows the opposite responses of cytosolic HuR in the SMG, and that the level of AUF1 in the kidney does not respond to DHT. In polyribosomes from female mouse SMG, HuR levels doubled after 6 h of DHT, but decreased by 80% after 24-and 48-h DHT treatment. Thus, the total level of HuR is regulated in two different androgen-responsive systems, as is the shuttling of HuR between different subcellular compartments. As AUF1 is responsive to androgen in the mouse SMG, but not in the kidney, tissue-specific posttranscriptional regulation of AU-rich messenger RNA metabolism could be mediated in part by differential androgen-dependent regulation of HuR and AUF1. (Endocrinology 142: 2361(Endocrinology 142: -2368(Endocrinology 142: , 2001 M ANY EARLY response genes, such as those encoding growth factors, cytokines, and transcription factors, contain AU-rich elements in their 3Ј-untranslated regions (3ЈUTRs) involved with their rapid turnover. These cis-acting AU-rich elements can bind specific trans-acting proteins to regulate the turnover of these highly labile messenger RNAs (mRNAs) via posttranscriptional mechanisms.
M
ANY EARLY response genes, such as those encoding growth factors, cytokines, and transcription factors, contain AU-rich elements in their 3Ј-untranslated regions (3ЈUTRs) involved with their rapid turnover. These cis-acting AU-rich elements can bind specific trans-acting proteins to regulate the turnover of these highly labile messenger RNAs (mRNAs) via posttranscriptional mechanisms. Two AU-rich binding proteins, HuR and AUF1, appear to have opposite effects on the stability of such mRNAs (1) (2) (3) (4) . In general, HuR prevents the degradation of AU-rich mRNAs, whereas AUF1 (also called hnRNP D) facilitates their degradation (3, (5) (6) (7) (8) (9) (10) (11) (12) (13) .
HuR (also called HuA in mice) is a member of the highly conserved ELAV (embryonic lethal abnormal vision) family of proteins and is expressed in many cell types (1, 7, 14 -16) . HuR has been shown to shuttle between the nucleus and cytoplasm (17) and has a nuclear shuttling sequence (HNS) similar to the nuclear localization sequence M9 in the well characterized shuttling protein, hnRNP A1 (18, 19) . The mechanisms governing the subcellular localization of different RNA-binding proteins remain obscure, although several pathways have been proposed for the modulation of their RNA and protein binding activities to regulate the targeting, translation, and turnover of the AU-rich mRNAs (1, 5, 6, 15, (17) (18) (19) .
Overexpression of HuR has been shown to stabilize AUrich mRNAs in several cell lines (18, 20, 21) , and the RNA binding activity of HuR has been shown to protect AU-rich mRNAs from degradation in response to various stresses or stimuli in several in vitro models (4, 14, 21) . The binding of HuR to a U-rich sequence in the 5ЈUTR of p27 mRNA protects this element from endoribonuclease cleavage, indicating a direct mechanism by which HuR can protect mRNA from endonuclease digestion (14) . Cytoplasmic HuR in HeLa cells is predominantly associated with polyribosomes (4) . In response to heat shock, HuR relocalizes along with mRNA to a protected nuclear/perinuclear compartment (4), suggesting that HuR can protect mRNA from degradation by altering its subcellular localization (14, 15, 18) . We previously demonstrated that androgen alters epidermal growth factor (EGF) mRNA at several posttranscriptional levels in the murine submaxillary salivary gland (SMG) model, and that androgen levels change the activities of several proteins that bind to a unique 23-base AU-rich element in the 3ЈUTR of EGF mRNA (22) . Additionally, we have recently shown that one AU-rich RNA-binding protein that is dramatically altered in the SMG, but not the kidney, is AUF1 (23) . The pattern of expression of AUF1 isoforms in the SMG is sexually dimorphic, and the cytosolic level of the p37/p42 pair of isoforms, which have the highest AU-rich binding and destabilizing activities (5, 6) , correlates directly with the circulating level of androgen in both male and female BALB/c mice (23) . In contrast to the destabilizing activity associated with AUF1, HuR generally stabilizes AUrich mRNAs (7) . We therefore performed experiments to determine whether androgen also regulates HuR in the androgen-responsive HepG2 cell line in vitro (23) and in nonreproductive tissues of mice in vivo.
Materials and Methods

Cell culture studies
HepG2 cells (0HB8065, passage 77, American Type Culture Collection, Manassas, VA) were initially expanded in Eagle's MEM with 10% FBS (Atlanta Biologicals, Atlanta GA), 2 mm l-glutamine, Earle's buffered salt solution, 1.5 g/liter NaHC0 3 , 0.1 mm nonessential amino acids, 1 mm sodium pyruvate, and 100 mg penicillin/streptomycin at 37 C in 5% CO 2 . Cells were then divided and grown in six-well plates in MEM/5% FBS to approximately 80% confluence (2-3 days). In the first experiment, cells were treated 10 nm dihydrotestosterone (DHT) or vehicle alone (0.1% ethanol) in fresh in MEM/5% FBS at 37 C for 48 h in triplicate. To prepare whole cell lysates, cells were rinsed with PBS, then scraped into high salt buffer (300 mm NaCl, 20 mm HEPES, 5 mm magnesium acetate, 5 mm potassium acetate, 1 mm EDTA, 1 mm sodium fluoride, 1 mm Na 3 VO 4 , 0.4 mm phenylmethylsulfonylfluoride, 0.4 mm leupeptin, 1 mm N-ethylmaleimide, 1% Triton X-100, and 1% Nonidet P-40). After homogenizing in a Dounce homogenizer (Kontes Co., Vineland, NJ), the lysate was briefly vortexed, incubated on ice for 20 min, then clarified by centrifugation at 10,000 ϫ g for 10 min at 4 C. In a second experiment, DHT (10 nm) was added to HepG2 cells for 0, 6, 24, and 48 h in fresh MEM/1% FBS in triplicate, and subcellular fractions were then prepared as described below. Subconfluent cultures of other cell lines were grown as previously described (LNCaP) (24) 
Animal studies
Experiments were conducted in accordance with NIH guidelines for animal treatment and housing. Litters of young adult (10 -12 weeks old) female BALB/c mice were divided into groups that contained representatives of each litter. The mice were injected with testosterone propionate (200 g, sc, every other day for up to 7 days and were killed at 3, 5, and 7 days) or DHT (200 g/day, sc, and killed at 6, 24, and 48 h) and then given a lethal ip injection of pentobarbital. The SMGs and kidneys from DHT-treated animals were removed and either processed immediately (for testosterone and orchiectomy studies) or snap-frozen in liquid N 2 and processed at a later date. The tissue samples were homogenized (Dounce) in 1 ml freshly prepared iced buffer A [20 mm HEPES (pH 7.4), 50 mm potassium acetate, 5 mm magnesium acetate, protease inhibitors (5 g/ml phenylmethylsulfonylfluoride, 10 m soybean trypsin inhibitor, and 10 m leupeptin), Prime ribonuclease inhibitor (1 U/l; 5 Prime-3 Prime, Inc., Boulder, CO), and 1 mm dithiothreitol]. Litters of young adult male BALB/c mice were divided into two groups containing equal numbers of representatives from each litter. Under pentobarbital anesthesia they underwent either a sham operation or orchiectomy and were killed 2 weeks later with a lethal dose of pentobarbital. The SMG and kidneys were removed from the male mice and homogenized as described above for female SMGs and kidneys.
Preparation of cytosol, nuclear. and polysome extracts
We centrifuged 1 ml homogenized (Dounce) tissues or cells prepared in buffer A at 800 ϫ g for 10 min at 4 C. The 800 ϫ g pellets were resuspended in sodium chloride (0.3 m final concentration) and centrifuged at 12,000 ϫ g for 10 min at 4 C, and the supernatants (nuclear extracts) were frozen at Ϫ70 C. The 800 ϫ g supernatants were layered on 4-ml cushions of 30% sucrose in iced buffer A, then centrifuged at 100,000 ϫ g for 2 h at 4 C, and the supernatants (cytosol extracts) were frozen at Ϫ70 C. The 100,000 ϫ g pellet was also resuspended in buffer A containing sodium chloride (0.3 m final concentration), incubated on ice for 1 h, and centrifuged at 10,000 ϫ g for 15 min at 4 C, and then the resultant supernatant (polysomal extracts) was frozen at Ϫ70 C (22) .
Western blotting
Protein concentrations in the samples were determined with bicinchoninic acid (Pierce Chemical Co., Rockford, IL) using BSA as a standard. Samples were boiled in SDS-PAGE sample buffer [final concentrations, 62.5 mm Tris-Cl (pH 6.8), 2% SDS, 10% glycerol, and 5% 2-mercaptoethanol] and briefly centrifuged, and approximately 50 g protein/lane were separated on SDS-polyacrylamide gels (12.5%) as previously described (23) . The proteins were then transferred to polyvinylidene difluoride membranes (Immobilon) using a Bio-Rad Laboratories, Inc. (Hercules, CA) Transblot apparatus as previously described (24) . We established that equal amounts of protein had been transferred from each lane by Ponceau staining of each membrane immediately after electrophoresis (23, 24) . Tris-buffered saline with 0.1% Tween-20 was used for all incubations and washes, and all incubations were performed for 1 h at 20 C. The membranes were blocked with 5% membrane blocking agent from Bio-Rad Laboratories, Inc. , then incubated with the appropriate primary antibody (see figure legends for antibody dilutions). The blots were washed three times for 15 min each time in Tris-buffered saline with 0.1% Tween-20 after each incubation step. Immunoreactive bands were visualized with secondary antibody conjugated to alkaline phosphatase and detected using enhanced chemifluorescence according to the manufacturer's instructions (Amersham Pharmacia Biotech, Aylesbury, UK). Immunoreactivity was quantified on a STORM imaging system (Molecular Dynamics, Inc., Sunnyvale, CA) and expressed in arbitrary fluorescence units using ImageQuant software (version 5.0, Molecular Dynamics, Inc.). Results are expressed as the mean Ϯ 1 sem, and statistical significance of differences was determined by ANOVA (StatView ϩ graphics, version 1.03, Abacus Concepts, Berkeley, CA). Digital images were prepared using Microsoft (Redmond, WA) PowerPoint (MacIntosh 1998 version).
Antibodies
Mouse monoclonal antibody to HuR was obtained from Santa Cruz Biotechnology, Inc. (sc5261, Santa Cruz CA), and alkaline phosphataseconjugated rabbit antimouse IgG antibody was purchased from Bio-Rad Laboratories, Inc. Two new antibodies to AUF1 were obtained from Tolnay (25) : antibody P1b preferentially detects the AUF1 isoforms that contain exon 2 (p45/p40), and antibody P3a preferentially detects the AUF1 isoforms missing exon 7 (p37/40).
Results
Survey of HuR levels in selected cell lines and mouse organs
HuR immunoreactivity running as a band of approximately 36 kDa was detected in homogenates from several different cell lines as well as in female and male SMG (Fig.  1) . Samples that contained high levels of HuR commonly also contained a slightly smaller immunoreactive HuR band, which has been described as a degradation product of HuR (4). Relatively high levels of HuR were found in HeLa, A431, HepG2, HT29, and Jurkat cells (and mouse spleen, see below), lower levels were found in LNCaP cells and female SMG, and the lowest level was in male SMG, which was approximately 1/10th of that found in female SMG. This suggested that HuR might be androgen responsive.
Androgen reduces HuR levels in total homogenates of HepG2 cells
As HepG2 cells express relatively high levels of HuR and are known to be androgen responsive (24), we determined whether HuR levels respond in this cell line. The level of HuR immunoreactivity on Western blots of total HepG2 cell extract fell approximately 75% after treatment with 10 nm DHT for 48 h ( Fig. 2A) . Extracts from cells treated with vehicle alone for 48 h had a mean HuR level of 27.1 Ϯ 1.5 relative fluorescence units, whereas the level in DHT-treated HepG2 extracts had fallen to 6.2 Ϯ 5.9 (n ϭ 3; P Ͻ 0.05; Fig. 2B ). Thus, total levels of HuR in this human hepatoblastoma cell line are reduced by androgen.
Androgen regulates the subcellular distribution of HuR in HepG2 cells
To determine how androgen levels influence the subcellular distribution of HuR, we prepared cytosolic, nuclear, and polyribosomal extracts from HepG2 cells. In control HepG2 cells, the HuR concentration was greatest in the nuclear compartment, similar to previous reports in HeLa cells (4, 18) , whereas cytosol and polyribosomes had approximately 1/10th the relative level of immunoreactivity detected in nuclei. DHT changed the relative level of HuR in all three subcellular compartments from HepG2 cells. A representative Western blot illustrating the change in the relative levels of HuR in all three subcellular compartments is shown in Fig. 3A , and the time course is plotted in Fig. 3B . HuR levels in both nuclei and cytosol declined, and by 48 h had fallen by 37% and 65%, respectively [from 23 Ϯ 2.28 to 14.5 Ϯ 9.7 (n ϭ 3; P Ͻ 0.05) and from 3.4 Ϯ 0.02 to 1.1 Ϯ 0.03 (n ϭ 3; P Ͻ 0.05); Fig. 3B ]. In contrast, the level of HuR in polyribosomes steadily increased, reaching 325% above the control value at 48 h (from 2.28 Ϯ 0.4 to 9.7 Ϯ 0.4; n ϭ 3; P Ͻ 0.05; Fig. 3B ). These data indicate that androgen influences the shuttling of HuR between subcellular compartments and suggest that this mechanism could be involved in the actions of androgen on the metabolism of AU-rich mRNAs that display posttranscriptional regulation by altering their targeted transport, stability, and/or translational efficiency (22, 26 -29) .
Tissue-specific sexual dimorphism of HuR in murine tissues
The overall levels of HuR in the female SMG and kidney are much higher than those in their male counterparts (Fig.  4) , although the female SMG contains only 10 -20% as much HuR as the female kidney and spleen (Fig. 4B) . The level in the male SMG is 20% of the level in the female SMG (0.23 Ϯ 0.1 vs. 1.3 Ϯ 0.05; n ϭ 3; P Ͻ 0.05), and in the male kidney the HuR level is 15% of that in the female (0.89 Ϯ 0.5 vs. 7.9 Ϯ 0.76; n ϭ 3; P Ͻ 0.05), whereas HuR levels in spleen were not different between the sexes (13.1 vs. 14.4, means of duplicate samples; Fig. 4B ). HuR levels in female and male thyroid samples were also not significantly different (not shown). 
Circulating androgen levels regulate HuR levels in several mouse tissues
The sexual dimorphism of HuR levels in the SMG and kidney prompted us to determine whether this reflects the difference in circulating levels of androgen. We therefore measured the levels of HuR in the SMG and kidneys of sham-operated males vs. males 2 weeks after bilateral orchiectomy. As shown in Fig. 5 , orchiectomy increased HuR levels in both SMG and kidney. The relative level of HuR in the male SMG increased 8-fold (from 0.15 Ϯ 0.003 to 1.32 Ϯ 0.12; n ϭ 3, P Ͻ 0.05) after orchiectomy, approaching the level of HuR present in control male kidneys (Fig. 5B) . In male kidney, orchiectomy doubled HuR levels (from 1.30 Ϯ 0.15 to 3.63 Ϯ 0.32; n ϭ 6; P Ͻ 0.05). Conversely, DHT treatment of female mice for 48 h decreased the relative level of HuR in the SMG by 85% (from 1.6 Ϯ 0.14 to 0.23 Ϯ 0.04; P Ͻ 0.05; n ϭ 4) and that in female kidney by 80% (from 9.24 Ϯ 0.4 to 1.86 Ϯ 0.79; P Ͻ 0.05; n ϭ 4) without altering the level of HuR in the female spleen (for pairs of samples, mean of 18.5 vs. 15.3; Fig. 6, A and B) . Treatment with testosterone propionate also decreased HuR levels in female SMGs within 3 days, but did not change HuR levels in the thyroid (not shown).
As orchiectomy of males has the opposite effect of that produced by treating females with DHT or testosterone, the sex difference in basal HuR levels in the same tissues indicates that the dimorphic expression of HuR reflects the difference in circulating androgen levels and is not exclusively due to a difference in neonatal imprinting.
DHT changes HuR levels in polyribosomal extracts of SMG from female mice
HuR levels in SMG polyribosomal extracts doubled when female mice were given DHT for 6 h (10.3 Ϯ 1.6 vs. 4.9 Ϯ 1.8; n ϭ 6; P Ͻ 0.05), whereas HuR levels decreased substantially in mice given DHT for longer periods (1.06 Ϯ 0.18 at 24 h and 1.8 Ϯ 0.35 at 48 h; n ϭ 6; P Ͻ 0.05 for both; Fig 7) . HuR levels in both the cytosol and nuclei of female SMG fell progressively (not shown), similar to the findings in HepG2 cells reported above. This transient increase in the level of polyribosomal HuR indicates that subcellular shuttling of HuR also occurs in vivo in response to androgen treatment.
FIG. 4.
Tissue-specific sexual dimorphism of HuR in mice. A, Western blots of homogenates of SMG, kidney, and spleen from pairs of control male and female BALB/c mice, analyzed as described in Fig  1. B, Graph of mean HuR levels. See Fig. 2 for details. SE bars are shown for SMG and kidney (n ϭ 4); only means are shown for spleen (n ϭ 2) (o, female tissues; f, male tissues).
FIG. 5. Orchidectomy changes
HuR levels in male SMG and kidney. A, Western blot. HuR in SMG and kidney in three males before and after orchiectomy compared with those in male and female spleen samples. Equal amounts of cell protein (50 g) were blotted and analyzed as described in Fig  1. B, Graph of the mean level of HuR before and after orchiectomy and in male and female spleen as described in Fig. 2 (n ϭ 3 for both control and orchidectomized male SMG and kidney samples; n ϭ 2 for spleen).
Tissue-specific androgen-dependent changes in AUF1 isoforms
We previously reported that androgen regulates the AUF1 isoform pattern in the mouse SMG, but not the kidney, when assessed with an anti-AUF1 antibody that detects the four AUF1 isoforms (23) . Two new antibodies, P1b and P3a, which preferentially detect AUF1 isoforms that contain exon 2 or that lack exon 7, respectively, have recently become available (25) . We therefore used these antibodies on the same blots previously probed with anti-HuR to directly compare the androgen-dependent changes in HuR with those in AUF1. Orchidectomy increased the level of p45 by approximately 400% in male SMG (from 5.4 Ϯ 2.9 to 27.9 Ϯ 2; n ϭ 3; P Ͻ 0.05) when the blot was probed with P1b antibody (Fig.  8, A and B) . The major AUF1 isoform detected by reprobing with P3a antibody in control male SMG cytosol is p37, and orchiectomy decreased its level by 85% (P Ͻ 0.05; n ϭ 3; Fig.  8, A and B) . Conversely, the major AUF1 isoform in SMG cytosol from female mice was p45, and DHT treatment decreased p45 levels by approximately 50% (from 5.1 Ϯ 0.8 to 2.4 Ϯ 1.1; n ϭ 6; P Ͻ 0.05) as detected with P1b (Fig. 8C) . DHT treatment increased p37 levels in female SMG cytosol by approximately 60% (from 6.6 Ϯ 0.7 to 10.7 Ϯ 0.7; n ϭ 6; P Ͻ 0.05), when the same blot was reprobed with P3a (Fig. 8C) . In kidney cytosol, the major AUF1 isoform was p37 (detected with P3a); very little p45 was detected (with P1b), and the FIG. 6. DHT changes HuR levels in female SMG, kidney and spleen. A, Western blot of whole homogenates of SMG, kidney, and spleen from two female mice after injection with vehicle alone or 200 g DHT for 48 h as described in Fig 1. B, Graph of the mean level of HuR as described in Fig. 2 (n ϭ 4 for SMG and kidney; n ϭ 2 for spleen).
FIG. 7.
DHT alters the level of HuR in polyribosomes from female SMG. A, Western blot. Equal amounts of polyribosomal SMG extract (50 g) from female mice injected with DHT for 0, 6, 24, and 48 h were analyzed as described in Fig 1. B , Graph of the time course of the changes in polysomal HuR levels after DHT treatment as described in Fig. 2 (n ϭ 6 at each time point).
levels of both isoforms did not change after DHT treatment (not shown). In addition to confirming our previous findings (23) , this further emphasizes the dramatic difference in androgen responsiveness of AUF1 and HuR between the two tissues. HuR levels fall in both kidney and SMG when androgen levels rise, and rise when androgen levels fall. In sharp contrast, AUF1 isoforms respond in the SMG, but not the kidney (23) . The tissue-specific difference between these two major AU-rich mRNA-binding proteins would appear to be an important factor in explaining the differences in androgen-dependent posttranscriptional regulation of mRNAs previously reported between these two tissues (22, 28, 29) .
Discussion
The finding that androgen can differentially alter subcellular levels of HuR provides a new insight into the regulation and function of HuR, suggesting a connection between the ability of HuR to stabilize labile mRNAs and the subcellular targeting of these mRNAs. Our data indicate that androgen regulates HuR shuttling from the nuclei and cytosol to the polyribosomal compartment in human HepG2 cells in vitro as well as in the murine SMG in vivo. Various other stimuli can shift the nucleo-cytoplasmic distribution of HuR (2, 4, 15, 17, 20, 21) . Our evidence of hormone-mediated shuttling of HuR to polyribosomes suggest that it may play a role in trafficking of newly synthesized mRNA to polyribosomes to facilitate translation. The relatively high level of HuR observed in polyribosomes compared with the relatively low level of AUF1 in polyribosomes [murine SMG (23) , HepG2 cells (unpublished), and HeLa cells (4)] indicates a spatial/ functional distinction between these two major AU-rich RNA-binding proteins, consistent with their playing opposing roles in the transport, stabilization, and/or translation of AU-rich mRNA in a tissue-specific fashion (1, 3, 4, 8) .
HuR can bind to a U-rich region, present in p27 mRNA (14) , that conforms to the consensus AU-rich element described by Lagnado et al. (30) . This element is involved in p27 mRNA turnover, and the binding of HuR prevents degradation of p27 mRNA by a specific endoribonuclease (14) . Several androgen-responsive gene transcripts that display posttranscriptional regulation, including EGF, EGF receptor, androgen receptor, and AUF1 itself (22, 23, 26, 27, 31, 32) , also contain AU-rich elements in their 3ЈUTRs, so androgendependent changes in HuR levels could affect the stability of these messages by protecting AU-rich elements from endoribonuclease degradation (14) .
The mechanisms that regulate the shuttling of HuR to different subcellular compartments are poorly understood. One molecular feature important in regulating HuR distribution is its nuclear shuttling sequence, HNS, located in the hinge region between the second and third RNA recognition motifs present in HuR (18) . When cells expressing fusion proteins bearing this HNS sequence are treated with actinomycin D, the level of the proteins in nuclei fall, whereas they rise in cytosol, indicating that active gene transcription is required for the nuclear import of HuR (18) . Moreover, the HNS has recently been shown to interact with several nuclear proteins that have acid-rich C-terminal tails to promote nuclear export of HuR (33) . The HNS is homologous to the M9 signal in hnRNP A1 (19) as well as to a nuclear retention FIG. 8 . Circulating androgen levels alter the expression of AUF1 isoforms, as detected with antibodies preferentially directed at specific AUF1 isoforms. A, The blot shown in Fig. 5A was stripped by washing in methanol for 30 min and then incubating in 0.2 N NaOH for 30 min as previously described (24) . It was reprobed twice, once with anti-P1b antibody (1:300; left) and then with antiP3a antibody (1:300; right). Two representative pairs of SMG samples (control and orchidectomized) shown in lanes 2-5 of Fig. 5A are displayed magnified, to show the different bands detected by the two antibodies. B, Graph of changes in AUF1 isoforms in male SMG after orchiectomy, as described in Fig 2. p45 (o) was detected with P1b antibody and p37 (f) with P3a antibody (n ϭ 3 for control and orchidectomized groups). C, Graph of changes in AUF1 isoforms in female SMG 6, 24, and 48 h after injection of 200 g DHT. p45 (o) was detected with P1b antibody, then p37 (f) was detected with P3a antibody (n ϭ 3 for control and DHT groups).
signal encoded by exon 7 of AUF1 (18, 34) . Exon 7 is only present in the p42 and p45 isoforms of AUF1, so enhanced nuclear retention of p45 (25, 34) might partially explain why DHT treatment does not decrease nuclear p45 levels as much as it decreases cytosolic p45 levels in the female SMG (23) .
HuR and the p37 isoform of AUF1 display inverse responses to androgen in the cytosol of the mouse SMG. We previously showed that increasing the level of androgen in female mice reduces the level of the p45/p40 pair while raising the level of the p37/p42 pair of AUF1 isoforms in SMG cytosol, whereas orchiectomy caused the opposite response in the cytosol of male SMG (23) . Higher levels of the p37/p42 AUF1 isoform pair correlate with enhanced cytoplasmic degradation of AU-rich mRNAs (5, 6) . Using two new isoform-specific anti-AUF1 antibodies (25) we have now independently confirmed these androgen-dependent changes in AUF1 isoforms and, more importantly, have correlated these changes with the very different changes in HuR. As HuR and AUF1 do not appear to possess endoribonuclease activity per se (6, 14) , it is possible that an androgen-responsive nuclease involved in AU-rich mRNA degradation could be selectively induced in polyribosomes or other subcellular fractions of certain androgen-responsive tissues.
Our observation that HuR levels in both the SMG and kidney respond to androgen sharply contrasts with the absence of an AUF1 response in the kidney (Ref. 23 and this report). The difference between the effects of androgen on AUF1 and HuR in these two tissues could partly explain tissue-specific differences in posttranscriptional regulation of AU-rich mRNAs as a consequence of the subcellular redistribution of HuR that occurs during androgen-dependent differentiation and/or hypertrophy in some nonreproductive tissues (22, 23, (27) (28) (29) . A recent survey of tissues from male mice at different stages of development found that the total levels of HuR and AUF1 changed in parallel (35) , but sexual dimorphism and the androgen-dependent changes in subcellular distribution of these two hnRNPs would not have been detected.
In several human cell lines previously reported to have high proliferation rates (Jurkat, HT29, HepG2, A431, and HeLa), we found relatively high basal levels of HuR, a finding similar to earlier reports on HuR levels in both human and murine cells (7, 17, 36) . In contrast, we found the level of HuR to be substantially lower in LNCaP cells, a prostate line derived from reproductive tissue that displays a low proliferation rate and high androgen responsiveness (37) . Thus, it will be interesting to determine how the metabolism and distribution of AU-rich mRNA correlate with the relative levels of HuR expressed in androgen-unresponsive human prostate cancer cell lines that display different rates of cell proliferation and metastasis (38, 39) , such as PC-3 cells, which have HuR levels 10 times greater than those in LNCaP cells (Sheflin, L. G., and S. W. Spaulding, unpublished). In summary, despite the broad tissue distribution of HuR (4, 7, 17, 36) , androgen-mediated cellular differentiation plays a pivotal role in regulating the expression and subcellular targeting of HuR in several tissues. Disruption of hormone regulation of HuR could result in alterations in the turnover of early response gene transcripts involved in cellular proliferation, transformation, and/or carcinogenesis (1, 2, 17, 40 -42) .
